FOXC2 Vital To Epithelial-Mesenchymal Transition In Breast Cancer; FDA-Approved Drug
Protein central to cancer stem cell formation provides new potential target Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development...
More... |
All times are GMT -7. The time now is 06:06 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021